STAT

JUNE 12, 2025

When House Republicans voted in the wee hours of the morning of May 22 to cut approximately $700 billion from Medicaid , they moved one step closer to rendering dangerously vulnerable the millions of Medicaid recipients struggling with mental illness and substance use disorder. Medicaid, which covers more than 72 million Americans, is the single largest payer of behavioral health services , which includes mental health and substance use disorder treatment.

345

345

Pharma Times

JUNE 12, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Levicept presents new LEVI-04 data at EULAR by John Pinching | 12th Jun 2025 | News Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025).

118

118

STAT

JUNE 12, 2025

As an adoptee who was placed in foster care at 18 months old, I’ve never known my full racial heritage, family tree, or medical history. People have often suggested I try 23andMe or a similar company to get more information on my genetics. But I’ve always felt uneasy about it. So, I felt a little vindicated when I saw the news that Regeneron Pharmaceuticals is set to acquire 23andMe , including its troves of customer data, for $256 million.

292

292

PhRMA

JUNE 12, 2025

As lawmakers in Lansing debate health care legislation, new evidence reveals a staggering—and deeply troubling—reality: big, tax-exempt hospitals in the state are marking up the price of prescription medicines by nearly $10 billion a year. The federal 340B program is running unchecked with limited transparency and accountability, and comprehensive federal reform is needed to stop abuse of the program.

Hospitals 79

Hospitals 79

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

JUNE 12, 2025

Taxpayers will send an estimated $86 billion to Medicare Advantage insurers this year to pay for supplemental benefits for their members, or 17% of total payments to those plans. But how that money is spent, and how much members actually use those benefits, remains a black hole, according to a new report from a group of Medicare experts. Medicare pays MA plans in the form of what’s known as rebates to help fund supplemental benefits, and that funding has shot up by more than 300% over the

324

324

STAT

JUNE 12, 2025

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults aged 18 to 59 who are at high risk of severe illness if they contract respiratory syncytial virus. Previously the vaccine, sold under the name mResvia, was only licensed for use in adults aged 60 and older.

Vaccines 321

Vaccines 321

pharmaphorum

JUNE 12, 2025

Novo Nordisk and tech giant NVIDIA have joined forces on a new project that aims to speed up drug discovery using generative AI.

98

98

STAT

JUNE 12, 2025

Systematic reviews, which involve pooling data from multiple studies and analyzing them together, are increasingly popular as a way to produce more authoritative conclusions than can be derived from the individual smaller papers. In recent weeks, systematic reviews have been used to justify policy around gender affirming care as well as in the MAHA report.

320

320

World Pharma News

JUNE 12, 2025

Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, announced it has secured exclusive worldwide rights to develop and commercialize the clinical-stage Werner helicase (WRN) covalent inhibitor VVD-214 (RO7589831), strengthening and complementing its innovative oncology development pipeline.

107

107

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

JUNE 12, 2025

If Health and Human Services Secretary Robert F. Kennedy Jr. wants to “clean up the corruption and conflicts” at HHS, he is going about it the wrong way. I study conflicts of interest at federal agencies. While industry influence is a widely shared concern, Kennedy’s dismissal of all the members of the Centers for Disease Control and Prevention vaccine advisory committee, and the rapid hiring of eight replacements , could easily misfire.

Vaccines 318

Vaccines 318

PharmaVoice

JUNE 12, 2025

A reputation is tough to build and easy to bruise. For drugmakers stuck in reputational limbo, embracing a clear direction and forward-thinking strategy can foster a rosier image.

130

130

STAT

JUNE 12, 2025

Why did Robert F. Kennedy Jr. abruptly fire all members of the expert panel that advises the Centers for Disease Control and Prevention on vaccines? Who are the new members that Kennedy named? And what does that all mean for the future of public health? We discuss all that and more on this on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.

Drug Pricing 228

Drug Pricing Vaccines 228

pharmaphorum

JUNE 12, 2025

MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.

Vaccines 109

Vaccines 109

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

JUNE 12, 2025

In a victory for the pharmaceutical industry, a U.S. appeals court upheld a lower court decision to halt a controversial Minnesota law that is designed to provide transparency into prescription drug pricing. The decision was issued as the result of a lawsuit filed three years ago by the Association for Accessible Medicines, which argued the law gives Minnesota the power to regulate interstate commerce and apply the law to prices charged in other states.

Drug Pricing 212

Drug Pricing Pharmaceutical Manufacturing 212

The Pharmacist

JUNE 12, 2025

Community pharmacy must ‘grow’ as a ‘key clinical service provider’ within primary care, NHS England’s national director for primary care and community services has suggested. Speaking at the NHS Confed Expo healthcare conference in Manchester on Wednesday, Dr Amanda Doyle said she recognised that community pharmacy felt ‘underwater currently’ but that she wanted its clinical […] The post Pharmacy must grow as ‘key clinical provider’, says NHSE primary care lead appeared first on The Pharm

Community Pharmacies 63

Community Pharmacies 63

STAT

JUNE 12, 2025

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Maybe I don’t say this enough: Thank you for being a STAT subscriber!  If you like what we do here, forward this email to a friend. They can get this newsletter every week through a STAT+ subscription, which is  50% off  through next Monday.

165

165

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -W

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

European Pharmaceutical Review

JUNE 12, 2025

Researchers have developed a once-weekly oral capsule with an innovative delayed drug release mechanism. This development could help certain patients, such as those with schizophrenia , to take their medicines more consistently. As the drug device can be delivered orally , the new pill “represents an important option that can assist with adherence for the many patients who would prefer oral medications versus injectable formulations,” explained Leslie Citrome, a Clinical Professor of psychiatry

Hospitals 52

Hospitals 52

The Pharmacist

JUNE 12, 2025

Eligible pharmacy students will be given financial help with travel and accommodation costs while on clinical placements, following a change in guidance from the Department of Health and Social Care (DHSC). MPharm students in England can now access the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF). The change […] The post Pharmacy students given access to placement funding appeared first on The Pharmacist.

59

59

Pharmafile

JUNE 12, 2025

Ascend Advanced Therapies, a contract development and manufacturing organisation based in Maryland, US, has received good manufacturing practice (GMP) certification for quality control (QC) testing at its site in Munich, Germany. This will streamline testing and release of adeno-associated (AAV)-based gene therapy. The Munich facility is now permitted to perform advanced commercial assays for DNA […] The post Ascend granted certification for quality control testing at Munich facility appea

59

59

European Pharmaceutical Review

JUNE 12, 2025

Regulatory bodies like the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) are emphasising the importance of data quality for AI applications in healthcare. High-quality and well-structured data and metadata are characterised by accuracy, consistency and completeness, which is essential for reliable insights and trustworthy AI outputs.

Drug Development 52

Drug Development Documentation Labelling Diabetes 52

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

JUNE 12, 2025

When you think of gases involved in your health, oxygen probably tops the list. But there’s another gas, nitric oxide, that quietly plays a crucial role in keeping your body running smoothly. Though it might sound like something from a chemistry lab, nitric oxide is made right inside your body. In fact, the discovery of this gaseous molecule led to the Nobel Prize in Physiology or Medicine in 1998 to Dr Robert F Furchgott, Dr Louis J Ignarro, and Dr Ferid Murad for their discoveries concerning n

Communication 87

Communication 87

Pharmaceutical Technology

JUNE 12, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Communication 52

Communication Hospitals Packaging 52

PharmaShots

JUNE 12, 2025

Shots: Novartis has reported P-IIIb ( APPULSE-PNH ) trial data assessing Fabhalta (iptacopan; 200mg, BID, PO) for 24wks. in 52 PNH adults with Hb levels ≥10g/dL who switched from anti-C5 therapies (eculizumab or ravulizumab) Trial showed a 2.01 g/dL mean Hb increase, with 92.7% pts achieving ≥12g/dL & no transfusions over 24wks. It also depicted improved fatigue per FACIT-Fatigue score (+4.88 at Day 84 & +4.29 at Day 168), along with sustained intravascular hemolysis control & resolv

59

59

Pharmafile

JUNE 12, 2025

Italian biopharma, Chiesi Group, and Key2Brain, a Swedish biotech, have agreed to advance the development of two blood-brain barrier (BBB)-crossing recombinant enzyme replacement therapies (ERT) for lysosomal storage disorders. These are ultra-rare diseases, including alpha-mannosidosis and Krabbe disease, that affect the central nervous system and have limited treatment options.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Viseven

JUNE 12, 2025

Speed and quality are no longer the only benchmarks for pharma and life sciences content creation. In pharma and life sciences, where compliance is a non-negotiable rule and tools often don’t play well together, marketers need more than just AI — they need a solution that connects the dots and respects the rules. That’s exactly the thinking that led us to conceptualize, create, and now release eVa — a new AI agent within the eWizard Content Experience Platform.

Labelling 52

Labelling 52

The Pharmacist

JUNE 12, 2025

The health secretary has outlined his ambitions to drive ‘much of what is done’ in hospitals towards ‘the high street’ and remote services over the next decade. Wes Streeting said the move would come as part of NHS reforms that would have ‘radical implications’ for health services, as the government shifts care closer to home. […] The post Health secretary to push care from hospitals towards ‘the high street’ appeared first on The Pharmacist.

Hospitals 58

Hospitals 58

PharmaShots

JUNE 12, 2025

Shots: The US FDA has approved mRESVIA (mRNA-1345) to prevent lower respiratory tract disease caused by RSV in individuals (18-59yrs.) at risk; expected to be available in US for the 2025–2026 respiratory virus season Approval was based on P-III trial assessing safety & immunogenicity of mRESVIA in adults (18-59yrs.) at increased risk for RSV-associated lower respiratory tract disease Trial met prespecified non-inferiority immunobridging criteria compared to adults (≥60yrs.) in P-III study ,

59

59